On the basis of outcomes, there was no clear winner from a trial that directly compared two modern devices used in patients undergoing percutaneous left atrial appendage (LAA) closure. But the devices ...
Boston Scientific is driving growth through innovation in its Watchman and ablation portfolios. The CLOSURE trial faced challenges due to procedural complications, but the OPTION trial expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results